Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report)’s stock price dropped 2% during trading on Friday . The stock traded as low as $1.47 and last traded at $1.47. Approximately 1,000 shares traded hands during mid-day trading, a decline of 21% from the average daily volume of 1,267 shares. The stock had previously closed at $1.50.
Silence Therapeutics Stock Performance
The stock has a 50 day simple moving average of $1.91 and a 200 day simple moving average of $4.38.
About Silence Therapeutics
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company's mRNAi GalNAc Oligonucleotide Discovery platform consists of precision engineered product candidates designed to target specific disease-associated genes in the liver.
Featured Articles
- Five stocks we like better than Silence Therapeutics
- 3 Small Caps With Big Return Potential
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- Investing in the High PE Growth Stocks
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
